Medical Cannabis Advocacy in Sub-Saharan Africa During the 1970s

The Legal Landscape Entering the 1970s

By 1970, cannabis (known regionally as dagga, bhang, matekwane, njemu, and dozens of other names) was prohibited across most of Sub-Saharan Africa. Colonial-era prohibition laws — many dating to the 1920s — had been retained or hardened by post-independence governments. South Africa's Abuse of Dependence-Producing Substances and Rehabilitation Centres Act of 1971 replaced earlier legislation and imposed severe penalties for possession and dealing ^[1]. The 1961 Single Convention on Narcotic Drugs, which classified cannabis in Schedule IV alongside heroin, had been ratified by numerous African states through the 1960s and 1970s and structured domestic policy ^[2] Strong evidence.

This is the essential context: the 1970s were a decade of prohibition consolidation, not reform. Any framing that portrays the era as one of active medical cannabis advocacy in the region misreads the historical record.

Traditional Medicinal Use vs. Organized Advocacy

Traditional medicinal use of cannabis in Sub-Saharan Africa is old, well-documented, and continued through the 1970s regardless of legal status. Brian du Toit's ethnographic work, culminating in Cannabis in Africa (1980), documented use across South Africa, Lesotho, Swaziland, and neighboring states for conditions including asthma, snakebite, malaria symptoms, and childbirth pain ^[3] Strong evidence. Sula Benet's earlier comparative work also noted African medicinal traditions ^[4].

But traditional use is not the same as advocacy. There is no evidence in the primary record of organized African civil-society campaigns during the 1970s pushing for legal medical cannabis access along the lines of what emerged later in California in the 1990s. Rastafarian communities in the Caribbean and, to a limited extent, in Southern and Eastern Africa argued for sacramental and healing use on religious grounds, but this was religious-liberty framing, not medical-regulatory advocacy Weak / limited.

Academic Pharmacology in the Region

The clearest 1970s scholarly engagement with cannabis in Sub-Saharan Africa came from pharmacologists and psychiatrists, not advocates. Frances Ames, a South African psychiatrist at the University of Cape Town, had published clinical observations on cannabis psychosis in 1958 and continued research into the 1970s ^[5]. Her work was clinical description rather than pro-legalization advocacy, though she later became a notable civil rights figure for unrelated reasons (documenting Steve Biko's treatment).

University of Cape Town and University of the Witwatersrand pharmacology departments engaged sporadically with cannabis chemistry during the decade, but Sub-Saharan African cannabis research in the 1970s was dwarfed by output from Israel (Raphael Mechoulam's group), the United States, and the United Kingdom Strong evidence. No African medical society issued a policy position calling for medical cannabis access during the 1970s that appears in the surviving record.

Isolated Legal and Political Moments

A few moments are sometimes retrospectively cited as "advocacy," though they fit that label loosely:

• South African commissions of inquiry: The Grobler Commission (1952) and subsequent policy reviews preceded the 1970s and did not recommend medical liberalization. The 1971 Act tightened, rather than loosened, restrictions ^[1].
• Rastafarian legal defenses: Throughout the 1970s in South Africa and later in Zimbabwe and other states, Rastafarian defendants raised religious-freedom defenses in possession cases. These were almost uniformly unsuccessful during the decade Weak / limited.
• Traditional healer organizations: Some traditional healers' associations, particularly in Southern Africa, quietly maintained that cannabis was part of their pharmacopoeia. This was descriptive practice rather than public advocacy Anecdote.

No African government during the 1970s created a medical cannabis access program. The first meaningful African medical cannabis regulatory frameworks did not appear until Lesotho (2017), Zimbabwe (2018), and South Africa (following the 2018 Constitutional Court private-use judgment) ^[6].

How the Myth Developed

Popular cannabis histories — particularly online — sometimes imply a robust African medical cannabis tradition that was somehow being formally "advocated for" in the 1970s. This conflates three distinct things:

1. Deep traditional medicinal use (real, well-documented, continuous).
2. Ethnobotanical scholarship documenting that use (real, but academic, not activist).
3. Organized political advocacy for legal medical access (essentially absent in the 1970s).

The conflation is retrospective. As post-2010 African cannabis reform accelerated, some commentators projected a longer advocacy lineage backward. The primary sources — legislation, medical journals, newspapers of record from the period — do not support that projection Disputed.

The honest history is that Sub-Saharan Africa entered the 1970s with widespread traditional cannabis use under prohibition, and exited the 1970s with that same pattern intact. Meaningful medical advocacy in the region is largely a 21st-century development, drawing on both traditional-use arguments and the international medical cannabis evidence base built elsewhere.

What We Don't Know

Archival research on 1970s African drug policy is genuinely limited compared to Anglo-American and European scholarship. It is possible that local-language newspapers, unpublished dissertations, or NGO records contain evidence of small-scale advocacy that has not entered the English-language historiography. If such records exist and become available, this article should be updated. What is currently defensible is a negative claim: no substantial organized medical cannabis advocacy movement in Sub-Saharan Africa in the 1970s appears in the accessible record No data.

Sources

How this page was made